Serum markers of cardiac fibrosis suffering from heart failure with preserved left ventricular ejection fraction upon ST-segment elevation myocardial infarction

Aim. Currently, there is no method which accurately predicts an adverse outcome of heart failure with a preserved left ventricular ejection fraction (HFpEF) upon ST-segment elevation myocardial infarction (STEMI). Here we studied the prognostic significance of procollagen type I C-terminal propeptid...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	A. V. Оsokina, V. N. Karetnikova, O. M. Polikutina, O. V. Gruzdeva, T. P. Solodilova, S. N. Kosareva, A. V. Motova, T. B. Pecherina, O. L. Barbarash
Format:	Artigo
Sprog:	Russo
Udgivet:	Kemerovo State Medical University 2021-09-01
Serier:	Фундаментальная и клиническая медицина
Fag:	st-segment elevation myocardial infarction cardiac fibrosis heart failure with preserved left ventricular ejection fraction adverse outcome
Online adgang:	https://fcm.kemsmu.ru/jour/article/view/436
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!